Gsa Capital Partners LLP Zai Lab LTD Transaction History

Gsa Capital Partners LLP

  • $1.32 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024
SELL
$13.72 - $21.55 $204,949 - $321,913
-14,938 Reduced 32.78%
30,635 $531,000
Q1 2024

May 03, 2024
BUY
$15.95 - $26.8 $551,104 - $925,993
34,552 Added 313.51%
45,573 $730,000
Q4 2023

Feb 16, 2024
BUY
$22.97 - $30.58 $253,152 - $337,022
11,021 New
11,021 $301,000
Q2 2023

Aug 14, 2023
BUY
$25.3 - $39.67 $670,981 - $1.05 Million
26,521 New
26,521 $735,000

Others Institutions Holding ZLAB

# of Institutions
121
Shares Held
46.7M
Call Options Held
223K
Put Options Held
588K
View Full List

About Zai Lab Ltd

ZLAB Quotes by TradingView
  • Ticker ZLAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,908,704
  • Market Cap $2.95B
  • Description
  • Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...
More about ZLAB
Track This Portfolio

Track Gsa Capital Partners LLP Portfolio

Follow Gsa Capital Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email